Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Notes Receivable

v3.7.0.1
Note 3 - Notes Receivable
6 Months Ended
Jun. 30, 2017
Notes to Financial Statements  
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]
Note
3:
Notes Receivable
 
Effective
July 2012,
the Company sold a company-owned clinic, including the license agreement, equipment, and customer base, in exchange for a
$90,000
unsecured promissory note. The note bore interest at
6%
per annum for
fifty-four
months and required monthly principal and interest payments over
forty-two
months, beginning on
August 2013.
The note matured in
January 2017
and was paid in full upon maturity. 
 
Effective
July 2015,
the Company entered into
two
license transfer agreements, in exchange for
$10,000
and
$29,925
in separate unsecured promissory notes.  The non-interest bearing notes require monthly principal payments over
24
months, beginning on
September 1, 2015
and maturing on
August 1, 2017.
  
Effective
May 2016,
the Company entered into
three
license transfer agreements, in exchange for
three
separate
$7,500
unsecured promissory notes.  The non-interest bearing notes require monthly principal payments over
six
months, beginning on
May 1, 2017
and maturing on
October 1, 2017. 
 
Effective
April 29, 2017,
the Company entered into a regional developer agreement for certain territories in the state of Florida in exchange for
$320,000,
of which
$187,000
was funded through a promissory note. The note bears interest at
10%
per annum for
42
months and requires monthly principal and interest payments over
36
months, beginning
November 1, 2017
and maturing on
October 1, 2020. 
 
The net outstanding balance of the notes as of
June 30, 2017
and
December 31, 2016
were
$202,000
and
$40,826,
respectively.